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Abstract: Micro-Raman spectroscopy is a very promising tool for medical applications, 
thanks to its sensitivity to subtle changes in the chemical and structural characteristics of 
biological specimens. To fully exploit these promises, building a method of data analysis 
properly suited for the case under study is crucial. Here, a linear or univariate approach 
using a R
2 determination coefficient is proposed for discriminating Raman spectra even 
with small differences. The validity of the proposed approach has been tested using Raman 
spectra of high purity glucose solutions collected in the 600 to 1,600 cm
−1 region and also 
from solutions with two known solutes at different concentrations. After this validation 
step, the proposed analysis has been applied to Raman spectra from oral human tissues 
affected by Pemphigus Vulgaris (PV), a rare life-threatening autoimmune disease, for 
monitoring disease follow-up. Raman spectra have been obtained in the wavenumber 
regions from 1,050 to 1,700 cm
−1 and 2,700 to 3,200 cm
−1 from  tissues of patients at 
different stages of pathology (active PV, under therapy and PV in remission stage) as 
confirmed by histopathological and immunofluorescence analysis. Differences in the spectra 
depending on tissue illness stage have been detected at 1,150–1,250 cm
−1 (amide III)   
and 1,420–1,450 cm
−1 (CH3 deformation) regions and around 1,650 cm
−1 (amide I) and 
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2,930 cm
−1 (CH3 symmetric stretch). The analysis of tissue Raman spectra by the proposed 
univariate method has allowed us to effectively differentiate tissues at different stages of 
pathology. 
Keywords:  oral tissues; Raman microspectroscopy; univariate data analysis; follow-up 
monitoring 
 
1. Introduction  
In the last years micro-Raman spectroscopy [1] has shown to be a very promising tool for specific 
molecular fingerprinting in medical applications. Its success has been strongly boosted by the 
development of specific data analysis methods enabling the extraction of the wealth of information 
embedded in Raman spectra of complex samples, such as human tissues, fluids and humours. When 
large numbers of patients and data are available multivariate methods have been employed for 
analysing blood and other human aqueous matrices [2-4] and pathological human tissues [5,6]. 
Principal Component Analysis (PCA) methods have been able to classify oral tissues into different 
categories depending on the stage of the specific disease (normal, inflammatory, premalignant and 
malignant) [7]. When a few samples have to be examined, different approaches for comparing Raman 
spectra have been developed and applied in order to evaluate the occurrence of changes in signal 
intensity or in spectrum peak configuration with respect to a reference signal [8-13]. In general, the 
information has been obtained from the direct comparison of selected band areas [8-10] or of single 
peak intensities [11,12], relevant to the sample state or configuration. When the spectrum 
modifications are relatively weak, it can be difficult to quantitatively evaluate the effect of possible 
changes in state or configuration on small spectral regions, because of the presence of noise, 
background or spurious signals. A global analysis of the spectrum can provide some advantages in the 
evaluation of spectral changes, especially when the spectra to be compared have a close configuration. 
Several correlation methods have been typically employed in these cases [14,15] in order to enhance 
similarities or correlation in the data sets.  
In this paper, a univariate approach is proposed for analyzing Raman spectra when only a few 
samples are available, as in the case of a rare pathology or in the initial stages of a pilot study. The 
validation and assessment steps have been performed using controlled samples, consisting of high 
purity glucose aqueous solutions and aqueous mixtures in which different glucose concentrations are 
present, together with other substances. After the assessment, the proposed approach has been applied 
to differentiate oral tissues from patients affected by Pemphigus Vulgaris (PV) at different illness 
stages in order to monitor disease progression and therapy efficacy. PV is a rare life-threatening 
autoimmune disease that causes blistering of the skin and oral cavity, being  characterized by the 
disruption of keratinocytes’ adhesion [16,17]. The follow-up monitoring of PV is usually accomplished 
by means of histological features and immunofluorescence analysis. However, alternative techniques 
for disease follow-up should be developed to better understand the disease progression and to avoid 
multiple biopsies.  Sensors 2011, 11  
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The proposed approach for spectrum analysis can be considered as an extension of the many 
methods reported in the literature for quantitatively comparing Raman signals [8-13] and it could be 
particularly useful for comparing Raman responses from different and independent samples of similar 
materials, such as tissue biopsies. In spite of their differences due to individual characteristics and 
history, previous work [5-7] has shown that a basic common profile may be expected for Raman 
responses from tissues of subjects in the same state of pathology. The method here proposed permits 
one  to find out the similarities in the spectra and to discriminate the spectra exhibiting possible 
anomalies, thus providing a powerful tool for the analysis of spectra with small differences.  
2. Experimental Section  
2.1. Sample Preparation and Data Acquisition 
Glucose aqueous solutions and aqueous mixed solutions of glucose and artificial sweeteners were 
used as control samples. High purity glucose powder (>99%) was purchased from Riedel de Haën AG 
(Buchs, Switzerland) and used without any further treatment. The main components of the commercial 
sweetener here used were sorbitol, mannitol, fructose and saccharin sodium as reported on the 
product’s label. A proper amount of glucose powder was dissolved in distilled water to obtain glucose 
concentrations, [Glu], in the 25 mM–1,050 mM range. Glucose and commercial sweetener were also 
dissolved in distilled water for preparing six samples with different relative concentrations as indicated 
in Table 1. 
Table 1. Composition of mixed solutions. Details on the used commercial sweetener 
available on request. 
Sample 
Sweetener  
weight fraction (%) 
Glucose  
weight fraction (%) 
A  100 0 
B  0 100 
C  90 10 
D  75 25 
E 50  50 
F  25 75 
 
Biopsies of oral tissues from patients with histological and immunofluorescence confirmed PV 
were used as complex samples. Patients (two subjects) with detectable titres of anti-Inter Cellular 
Substance Immunoglobuline G (ICS IgG) and at least two oral/skin lesions were considered as “active 
PV”, whereas those taking immunosuppressive agents at the time of biopsy collection were referred to 
as “PV in therapy” (two subjects). Patients having no more clinical evidence of blisters and ICS  
titres <1:40 at the end of the therapy were considered as “PV in remission” (recovered—two patients). 
Informed consents were obtained from all participants prior to biopsy. Two oral biopsies were obtained 
from each patient: one was used for direct immunofluorescence tests, and the other for Raman 
investigations. Samples were put in ice-cold saline immediately after removal and used immediately. 
When storage was necessary, samples were frozen at liquid nitrogen and stored at   Sensors 2011, 11  
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–80 °C. They were taken out and passively thawed immediately before recording the spectra. Such a 
procedure had been shown to not provoke changes in the Raman spectra of tissues [18]. 
Samples were examined using a micro-Raman spectrometer equipped with a confocal inverted 
microscope (Horiba-Jobin Yvon, Jongjumeau, France) with a grating of 1,800 grooves/mm, a liquid 
nitrogen cooled CCD detector (1,024 × 256 chip size) and a 17 mW He-Ne laser operating at 633 nm. 
The laser light was focused on the sample surface by means of a 50× optical objective (Olympus 
MPLAN 50×/0.75). The laser excitation spot has dimension of about 20 μm and the actual analyzed 
area is estimated in about 15 μm
2 for the microscope configuration adopted with a laser power at 
sample level equal to few mW. The micro-Raman spectra were detected in the 600–1,600, 1,000–1,700 
and 2,700–3,200 cm
−1 wavenumber shift regions. The spectra were obtained using accumulation times 
of 600 seconds. For each samples measurements were performed three times on different sites 
obtaining a total of one hundred files. 
Spectra were preliminarily analyzed using the application routines provided by the software 
package (“SpectraMaxTM Software” User Guide, Jobin-Yvon Inc., Edison, NJ, USA) controlling the 
whole data acquisition system. The spectra typically show a smeared background signal, with intensity 
of order of about 80% of the whole average intensity. A baseline correction program from the data 
acquisition software is used. The procedure consists in fixing some points of the spectra (in our case 
four points) and to subtract to the experimental data the cubic curve obtained by the fit of this fixed 
points. Typically the background level is weakly dependent on the wavenumber position, with respect 
to the Raman component of the signal, and this operation, in spite of its intrinsic arbitrariness weakly 
influences the information and repeatability of the process. No further treatment has been done before 
the comparison of the data by means of linear regression.  
For signal interpretation the complex spectra were also analyzed in terms of convoluted Lorentzian 
shaped vibration modes [19,20]. Peaks constituting the spectrum were manually selected in order to 
define the starting conditions for a best-fit procedure. The best-fit procedure was then performed to 
determine convolution peaks with optimised intensity, position and width. Its performance was 
evaluated by means of the χ
2
 parameter defined, as usual, by the following formula: 
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where the Actual and Calculated are the measured and calculated data, respectively, RMSNoise is the 
estimated Root Mean Square noise in the Actual data over the fitted region, n is to the number of data 
points in the fitted region and f refers to the total number of variables from the peak and baseline 
functions. Thus, n-f is the number of degrees of freedom. The Levenberg-Marquardt algorithm was 
employed to adjust every variable for each peak in an attempt to minimize the χ
2 parameter. This 
procedure was extremely useful for correctly determining the peak positions, widths, heights and areas 
of a set of overlapping peaks. 
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2.2. Univariate Data Analysis 
For each wavenumber point, Raman intensity of the spectrum (yi variable) is compared with the 
corresponding value of a reference spectrum (xi variable), referring to a sample in pristine condition or 
to a solution with known concentration. In order to overcome constraints related to the possible 
different scale of the experimental data, the data set is directly correlated with a linear scaling of the 
reference signal. This means to do a linear regression or univariate analysis of the data. The basic 
assumption is that the spectrum Y (containing the n data yi) is a linear function of the reference 
spectrum X (containing the n data xi). All variations with respect to the reference signal are considered 
as a perturbation term εi:  
i i i p mx y ε + + =        ( 2 )  
If no structural change occurs in the substance generating the Raman spectra, the term εi depends 
only on the experimental conditions and we can assume that it has random values that follow a 
Gaussian distribution, with mean 0 and variance σx, which does not depend on the index i [19]. This 
assumption implies that the yi are also normally distributed, with σy = σx. Regression analysis allows to 
determine, by means of a least square fit of data yi with respect to xi, the parameters m and p and to 
identify the linear dependence. A parameter useful to check how well a regression equation fits the 
data is the sample coefficient of determination, R
2 [14, 21]. It is defined as:  
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where  y is the average value of vector Y. 
R
2 ranges from 0 for uncorrelated data, to 1 for perfect linear dependence. When the error ε is 
purely random, the value of R
2 is equivalent to the square of the covariance ryŷ, calculated for the 
vector Y and the prediction vector Ŷ having components ŷi = mxi + p, which is defined as [14,19]:  
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R
2 is thus an index of the correlation between the considered set of data and the linear dependence 
on the reference signal, as we have postulated. The linear regression was evaluated on a number of 
points ranging between 500 and 700. Due to the high number of points considered, the values reported 
for R
2 in the next paragraph imply a high level of significance. 
3. Results and Discussion  
The above described univariate or linear regression approach has been firstly applied to aqueous 
glucose solutions to simulate an experimental situation in which Raman spectra were obtained from 
different samples with no structural differences. In Figure 1a the spectra of two glucose solutions at 
nominal concentrations cx = 1,050 mM (reference data, X) and cy = 250 mM (Y data) are shown. The 
spectra have been analyzed in terms of Lorentzian shaped vibration modes as reported in previous 
section and in refs. [19,20]. The displayed interval represents the fingerprint region and is the most Sensors 2011, 11  
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significant for the investigated samples. The presence of the characteristic bands of the α anomer at 
789, 855, 919, 1,336 and 1,371 cm
−1 and those of β anomer at 1,073, and 1,128 cm
−1 indicates that 
glucose in solution is a mixture of the two anomers with s predominance of the β configuration, as 
indicated by their relative intensities [22,23]. The peaks at 1,401 and 1,430 cm
−1 can also be attributed 
to glucose, as reported in Reference [24]. The contributions at 968, 1,036 and 1,524 cm
−1 can be 
related to some impurities present even in the high purity glucose powder (>99%) employed in the 
present experiments. The histogram of the residual values (εi = yi − mxi − p) normalized to the value of 
standard deviation σy is shown in Figure 1b. As is evident, the distribution follows a Gaussian 
dependence, according to the assumption of our hypothesis. In this case, R
2 has a quite high value  
(R
2 = 0.910), close to 1, indicating a good correlation between the two Raman spectra, as expected. In 
fact, by scrutinizing Figure 1(a), it comes clear that the two spectra differ in intensities and noise 
characteristics, due to the different glucose content, but the main features are preserved. The 
differences between the spectra slightly affect the R
2 value calculated with respect to the spectrum of 
the solution at the highest glucose concentration (1,050 mM), which has been selected as reference 
data. R
2 high value indicates that the spectra are very similar.  
Figure 1.  (a) Raman spectra (600–1,600 cm
−1 spectral region) of aqueous glucose 
solutions at two different glucose concentrations (1,050 mM and 250 mM).   
Different arbitrary units are used for the vertical axis of the two spectra. The attributions of 
the main peaks are the following: 789 cm
−1: α—anomer; 855 cm
−1: α—anomer; 919 cm
−1: 
α—anomer; 1,073 cm
−1:  β—anomer; 1,128 cm
−1:  β—anomer; 1,271 cm
−1: glucose;   
1,336 cm
−1:  α—anomer; 1,371 cm
−1:  α—anomer; 1,459 cm
−1: glucose [22-24].   
(b) Histogram of the εi values (see text). The residual values of the linear regression of the 
two spectra have a Gaussian dependence.  
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This approach can be extended to evaluate, in a simple way, the spectrum similarity for all the 
investigated aqueous glucose solutions (with glucose concentration ranging from 25 to 1,050 mM). 
The corresponding spectra, acquired under the same experimental conditions, are shown in Figure 2(a). 
These spectra are obviously characterized by the spectral features already described for Figure 1(a). As 
expected, they have similar main characteristics even though intensity and noise contributions are 
different. The value of R
2, obtained by comparison to the reference spectrum,
 as a function of glucose 
nominal concentration is shown in Figure 2(b). For concentrations lower than 125 mM, the Raman 
signal from glucose becomes comparable to that generated by noise and the correlation with the 
reference signal decreases abruptly.  
Figure 2. (a) Raman spectra (600–1,300 cm
−1 spectral region) of aqueous glucose 
solutions at different glucose concentrations (range: 25–1,050 mM). (b) R
2 determination 
coefficient (95% confidence level) resulting from the linear regression of Raman spectra 
from glucose solutions in water as a function of the nominal concentration. The analysis 
has been performed by considering the spectrum from the solution with the highest 
concentration (1,050 mM) as reference.  
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To further test this univariate approach, it has been applied to the spectra from the second set of 
control samples. These solutions, composed of glucose and artificial sweetener in distilled water, were 
prepared to simulate samples with different chemical compositions. The experimental spectra are 
shown in Figure 3. Also in this case the spectra of samples have been analyzed as previously reported. 
In particular for sample A (pure sweetener) the peaks at 639 cm
−1, 708 cm
−1 and 881 cm
−1 are assigned 
to fructose, the peaks at 878 cm
−1, 941 cm
−1 and 1,049 cm
−1 can be ascribed to mannitol and sorbitol, 
while the other two peaks at 1,130 cm
−1 and 1,246 cm
−1 are due to the contribution of mannitol [25-27]. Sensors 2011, 11  
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Figure 3. Raman spectra of aqueous solutions of bare sweetener (A), of glucose (B) and of 
sweetener/glucose mixtures with decreasing weight fraction of sweetener of 90%, 75%, 
50% and 25% (C, D, E and F, respectively). The attribution of the main peaks for sample 
A spectrum are the following: 639 cm
−1: fructose; 708 cm
−1: fructose; 878 cm
−1: mannitol 
and sorbitol; 881 cm
−1: fructose; 941 cm
−1: sorbitol and mannitol; 1,049 cm
−1: sorbitol and 
mannitol; 1,130 cm
−1: mannitol; 1,246 cm
−1: mannitol [25-27].  
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By inspecting the figure, it comes clear that the spectra of C, D, E and F samples are a 
superposition of the spectra of pure sweetener (sample A) and pure glucose (sample B), as expected. 
Also in this case the linear regression approach has been applied by considering, in turn, both spectra 
of samples A and B as reference, the results being shown in Figure 4. In both the cases the approach 
seems to work well. In fact, when the pure glucose solution is used as reference, the R
2 coefficient 
reaches its highest value (close to 1, meaning high similarity) when the reference spectrum is 
compared to that of pure glucose solution and has decreasing value when the glucose content 
decreases. The lowest similarity (lowest R
2 value, close to 0) is obtained when the spectrum of the pure 
sweetener solution is analyzed. Specular results have been obtained when the spectrum of the pure 
sweetener is used as reference. In that case, the highest correlation (and, thus, the highest similarity) is 
observed when the spectrum of the pure sweetener is considered, while R
2 assumes a value close to 0 
when the spectrum of pure glucose is compared with the reference. It’s worth noting that the R
2 values 
cover all the available range (0–1) and that there is a clear dependence on the sample chemical 
compositions, thus suggesting the ability of the method to discriminate between spectra, even when the 
differences are small. Sensors 2011, 11  
 
 
8317
Figure 4. R
2 coefficient
 values (95% confidence level) for the linear regression of Raman 
spectra of different glucose/sweetener mixtures as a function of the sweetener weight 
fraction (in %). Filled dots represent the values obtained by using the bare sweetener signal 
(from sample A) as reference. With empty dots the results obtained by using the pure 
glucose spectrum (from sample B) as reference are shown.  
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These encouraging results with samples of increasing degree of complexity have boosted us to 
apply the proposed approach to very complex Raman spectra as those from oral tissues from patients 
affected by PV at different illness stages that are characterized by different chemical and structural 
properties [16,17] in order to monitor the disease evolution and the therapy efficacy.  
Representative Raman spectra (1,050–1,700 cm
−1 spectral region) of oral biopsies from PV affected 
patients, from patients under therapy and from patients in a remission stage of illness (recovered) are 
shown in Figure 5(a,b,c), respectively. Main structures around 1,150 cm
−1 (C-C stretch and COH 
deformation), 1,225 cm
−1 (amide III), 1,340 cm
−1, 1,430–1,450 cm
−1 (CH3 deformation), 1,560 cm
−1 
and 1,636 cm
−1 (amide I) are observed in all the spectra (see references [28] and [29] for attributions), 
their shape and intensity may be dependent on tissue illness stage. For instance, in Figure 5(a) very 
poor structures in the initial 1,250–1,400 cm
−1 region are found in the spectrum of PV active tissues. 
This finding is related to the decreasing content of phospholipids (whose Raman features are known to 
fall in this region) in diseased tissues compared to normal ones [7]. On the other hand, the region 
around 1,500–1,650 cm
−1 (Figure 5(a)—PV active) is rich in structural features, due to major 
contributions from proteins [7,29]. These findings are similar to previous literature reports about 
Raman spectroscopy on normal and cancerous tissues. Pathologies generally do not cause the 
appearance and the disappearance of peaks and bands in tissue Raman spectra, rather they cause the 
modification of specific Raman feature structures [7,18,29]. In particular, the outlined changes confirm 
that the spectrum of normal oral tissue is closer to the lipid spectrum, while the spectra of malignant 
samples are rich in features assignable to proteins [7,18,30].  Sensors 2011, 11  
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Figure 5. Raman spectra of oral tissue biopsies from PV affected patients (a), patients 
under drug therapy (b) and patients in the remission stage of illness (c) in the wavenumber 
range 1,050–1,700 cm
−1.  
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Figure 6. Raman spectra of oral tissue biopsies from PV affected patients (a), patients 
under drug therapy (b) and patients in the remission stage of illness (recovered) (c) in the 
wavenumber range 2,700–3,200 cm
−1.  
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In Figure 6, representative spectra (2,700–3,200 cm
−1 wavenumber region) of tissues from oral 
biopsies from affected PV patients, from patients under therapy and from patients in remission stage of 
illness (recovered) are shown in Figure 6(a,b,c) respectively. Samples from two different subjects have Sensors 2011, 11  
 
 
8319
been considered for each physiological state. Changes of main components at 2,853 cm
−1 (CH2 
symmetric stretch), 2,874 cm
−1 (CH stretch), 2,931 cm
−1 (CH3 symmetric stretch), 2,961 cm
−1 (CH3 
asymmetric stretch) and 3,061 cm
−1 (CH olefinic stretch) can be easily observed, depending on tissue 
illness stage. These structures are generally attributed to lipid contents and can be sensitive to tissue 
biochemical and structural changes [29].  
The univariate approach has been applied to the oral tissue spectra, considering the two different 
wavenumber ranges. By taking one spectrum from tissues of recovered patients as reference, the R
2 
determination coefficient values have been obtained and are reported in Figure 7 for the two examined 
spectral ranges (similar results were obtained for whatever spectrum of recovered patients we 
selected).  
Figure 7. R
2 values (95% confidence level) resulting from linear regression analysis of 
Raman spectra relative to oral biopsies from (recovered) patients in the remission stage of 
illness, from patients under drug therapy and from affected PV patients in the wavenumber 
1,050–1,700 cm
−1 region (a) and 2,700–3,200 cm
−1 region (b). Columns indicate the mean 
of R
2 values. The vertical bars on the top of columns indicate the R
2 variability range.  
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For both the spectral regions, the R
2 parameter has the same behaviour, even though for the   
1,050–1,700 cm
−1 region the trend is more evident. In particular, when spectra acquired from tissues at 
the same illness stage are compared, the R
2 coefficient is larger than 0.9, confirming that in spite of 
their differences due to individual characteristics and history, the Raman responses of tissues of 
subjects in the same state of pathology show a basic common profile, as reported in [5-7]. Since the 
spectra of samples corresponding to different illness stages are different from that of the reference, the 
R
2 coefficient values decrease and in particular become very low for the spectra of tissue of PV active 
patients. Hence, it is evident that this univariate analysis may provide quantitative information on 
differences among tissues from patients at different stages of illness in the two wavenumber ranges 
under investigation, in agreement with our previous results on serum samples [31]. Sensors 2011, 11  
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Moreover, the present results confirm the possibility of also using high wavenumber ranges for 
tissue characterization of oral tissues and for “in vivo” applications [32-35]. In fact, the use of Raman 
spectroscopy in the fingerprint spectral region (800–1,800 cm
−1) in combination with fiber optics is not 
easy due to the strong background signal generated in the optical fiber. The necessary suppression of 
this background signal leads to complicated fiber optic probe designs. As a consequence, probes are 
relatively large and inflexible, expensive, and it is difficult to achieve reproducible performance with 
them. In contrast, the high wavenumber spectral region from 2,500 to 3,800 cm
−1 is virtually free of 
signal contributions from the fused-silica-based optical fibers. This provides a major advantage in that 
fiber optic probes for in-vivo applications can have very simple designs. 
4. Conclusions  
The proposed univariate method, based on the calculation of the R
2 determination coefficient, has 
been proven to be able to quantitatively discriminate complex Raman spectra obtained from human 
oral tissues depending on their illness stage in order to monitor disease evolution and therapy, and also 
when a small number of spectra is available as for a rare pathology like PV. This ability has been 
demonstrated for low and high wavenumber spectral regions. It is worthwhile to mention that the use 
of high wavenumber spectral region could reinforce the potential of Raman spectroscopy for “in vivo” 
applications. This approach can be the starting point for a systematic “in vivo” investigation over a 
wide number of clinical cases to statistically confirm and to fully assess the reliability of the proposed 
technique for disease follow-up monitoring. 
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